GLP-1 weekly · EP 1 · Jul 13, 2026
The Obesity Pill Race Just Got Real
This week in GLP-1 weekly
Papers covered
- Every obesity drug, rankeddoi:10.1136/bmj-2026-372161
- Orforglipron pill works in T2Ddoi:10.1186/s13098-026-02218-9
- Orforglipron liver safety confirmeddoi:10.1111/dom.71032
- Orforglipron drug interactions mappeddoi:10.1002/cpt.70377
- Tirzepatide softens stiff arteriesdoi:10.1016/j.obpill.2026.100291
Your field, every week
Get this for your own field.
Sciport turns the newest papers in your corner of the literature into a short weekly video like this one — auto-curated, delivered to your inbox. First episode’s on us.
Generate your first video →